{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T17:45:12Z","timestamp":1768585512215,"version":"3.49.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["AES-2021"],"award-info":[{"award-number":["AES-2021"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI21\/01100"],"award-info":[{"award-number":["PI21\/01100"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019717","name":"AstraZeneca Espa\u00f1a","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019717","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022302","name":"Societat Catalana de Pneumologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022302","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020231","name":"Fundaci\u00f3 Catalana de Pneumologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020231","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de Bronconeumolog\u00eda"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.arbres.2023.07.026","type":"journal-article","created":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T21:45:50Z","timestamp":1691185550000},"page":"736-742","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Role of Inflammatory Phenotype in Patients With Exacerbation-prone Asthma and Ongoing Therapy"],"prefix":"10.1016","volume":"59","author":[{"given":"Mar\u00eda Florencia","family":"Pilia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jes\u00fas","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donghai","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Romero-Mesones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Espejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amaia","family":"Ojanguren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Antonia","family":"Ramon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I\u00f1igo","family":"Ojanguren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arbres.2023.07.026_bib0185","doi-asserted-by":"crossref","first-page":"2102730","DOI":"10.1183\/13993003.02730-2021","article-title":"Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes","volume":"59","author":"Reddel","year":"2021","journal-title":"Eur Respir J [Internet]"},{"key":"10.1016\/j.arbres.2023.07.026_bib0190","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.arbres.2021.05.010","article-title":"Spanish Asthma Management Guidelines (GEMA) VERSION 5.1. Highlights and controversies","volume":"58","author":"Plaza","year":"2022","journal-title":"Arch Bronconeumol [Internet]"},{"issue":"10118","key":"10.1016\/j.arbres.2023.07.026_bib0195","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(17)30879-6","article-title":"After asthma: redefining airways diseases","volume":"391","author":"Pavord","year":"2018","journal-title":"The Lancet"},{"key":"10.1016\/j.arbres.2023.07.026_bib0200","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1164\/rccm.201810-1931CI","article-title":"Mechanisms and management of asthma exacerbations","volume":"199","author":"Ramsahai","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2023.07.026_bib0205","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1183\/09031936.05.00037905","article-title":"Risk factors of frequent exacerbations in difficult-to-treat asthma","volume":"26","author":"ten Brinke","year":"2005","journal-title":"Eur Respir J [Internet]"},{"key":"10.1016\/j.arbres.2023.07.026_bib0210","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1164\/rccm.200601-007OC","article-title":"Mortality in patients hospitalized for asthma exacerbations in the United States","volume":"174","author":"Krishnan","year":"2006","journal-title":"Am J Respir Crit Care Med [Internet]"},{"key":"10.1016\/j.arbres.2023.07.026_bib0215","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/cea.12179","article-title":"Frequent exacerbators \u2013 a distinct phenotype of severe asthma","volume":"44","author":"Kupczyk","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.arbres.2023.07.026_bib0220","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jaci.2010.04.021","article-title":"The role of viruses in acute exacerbations of asthma","volume":"125","author":"Jackson","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.arbres.2023.07.026_bib0225","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.arbres.2021.10.007","article-title":"The role of viral infections on severe asthma exacerbations: present and future","volume":"58","author":"Ojanguren","year":"2022","journal-title":"Arch Bronconeumol [Internet]"},{"key":"10.1016\/j.arbres.2023.07.026_bib0230","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/cea.12762","article-title":"Exacerbation risk in severe asthma is stratified by inflammatory phenotype using longitudinal measures of sputum eosinophils","volume":"46","author":"Walsh","year":"2016","journal-title":"Clin Exp Allergy [Internet]"},{"key":"10.1016\/j.arbres.2023.07.026_bib0235","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1164\/rccm.201602-0419OC","article-title":"Inflammatory and comorbid features of patients with severe asthma and frequent exacerbations","volume":"195","author":"Denlinger","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2023.07.026_bib0240","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S2213-2600(15)00367-7","article-title":"Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study","volume":"3","author":"Price","year":"2015","journal-title":"Lancet Respir Med [Internet]"},{"key":"10.1016\/j.arbres.2023.07.026_bib0245","article-title":"Exhaled nitric oxide levels and blood eosinophil counts independently associate with wheeze and asthma events in National Health and Nutrition Examination Survey subjects","volume":"132","author":"Malinovschi","year":"2013","journal-title":"J Allergy Clin Immunol [Internet]"},{"key":"10.1016\/j.arbres.2023.07.026_bib0250","doi-asserted-by":"crossref","first-page":"1601526","DOI":"10.1183\/13993003.01526-2016","article-title":"ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests","volume":"49","author":"Coates","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2023.07.026_bib0255","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1164\/ajrccm.154.2.8756799","article-title":"Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid phase measurements","volume":"154","author":"Pizzichini","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2023.07.026_bib0260","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/j.1365-2222.2012.04004.x","article-title":"Bronchial inflammation and hyperresponsiveness in well controlled asthma","volume":"42","author":"Mu\u00f1oz","year":"2012","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.arbres.2023.07.026_bib0265","doi-asserted-by":"crossref","first-page":"e78304","DOI":"10.1371\/journal.pone.0078304","article-title":"Sputum inflammatory profile before and after specific inhalation challenge in individuals with suspected occupational asthma","volume":"8","author":"S\u00e1nchez-Vidaurre","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.arbres.2023.07.026_bib0270","first-page":"378","article-title":"The MEGA Project: a study of the mechanisms involved in the genesis and disease course of asthma. Asthma cohort creation and long-term follow-up","volume":"54","author":"Mu\u00f1oz","year":"2018","journal-title":"Arch Bronconeumol [Internet]"},{"key":"10.1016\/j.arbres.2023.07.026_bib0275","first-page":"1","article-title":"The skin prick test \u2013 European standards","volume":"3","author":"Heinzerling","year":"2013","journal-title":"Clin Transl Allergy [Internet]"},{"key":"10.1016\/j.arbres.2023.07.026_bib0280","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2023.07.026_bib0285","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1183\/09031936.00080312","article-title":"Multi-ethnic reference values for spirometry for the 3\u201395-yr age range: the global lung function 2012 equations","volume":"40","author":"Quanjer","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2023.07.026_bib0290","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.arbres.2017.07.015","article-title":"Spanish Guidelines on the evaluation and diagnosis of bronchiectasis in adults","volume":"54","author":"Mart\u00ednez-Garc\u00eda","year":"2018","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2023.07.026_bib0295","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2214\/ajr.165.2.7618537","article-title":"CT findings in bronchiectasis: limited value in distinguishing between idiopathic and specific types","volume":"165","author":"Reiff","year":"1995","journal-title":"Am J Roentgenol [Internet]"},{"key":"10.1016\/j.arbres.2023.07.026_bib0300","doi-asserted-by":"crossref","first-page":"281","DOI":"10.18176\/jiaci.0816","article-title":"Exacerbations among patients with asthma are largely dependent on the presence of multimorbidity","volume":"33","author":"Dom\u00ednguez-Ortega","year":"2022","journal-title":"J Investig Allergol Clin Immunol [Internet]"},{"key":"10.1016\/j.arbres.2023.07.026_bib0305","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1164\/rccm.201909-1813OC","article-title":"Evidence for exacerbation-prone asthma and predictive biomarkers of exacerbation frequency","volume":"202","author":"Peters","year":"2020","journal-title":"Am J Respir Crit Care Med [Internet]"},{"key":"10.1016\/j.arbres.2023.07.026_bib0310","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.jaci.2014.08.015","article-title":"Development and validation of a novel risk score for asthma exacerbations: the risk score for exacerbations","volume":"135","author":"Bateman","year":"2015","journal-title":"J Allergy Clin Immunol [Internet]"},{"key":"10.1016\/j.arbres.2023.07.026_bib0315","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.jaci.2016.01.044","article-title":"Simultaneously increased fraction of exhaled nitric oxide levels and blood eosinophil counts relate to increased asthma morbidity","volume":"138","author":"Malinovschi","year":"2016","journal-title":"J Allergy Clin Immunol [Internet]"},{"key":"10.1016\/j.arbres.2023.07.026_bib0320","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/thoraxjnl-2014-205634","article-title":"External validation of blood eosinophils, FENO and serum periostin as surrogates for sputum eosinophils in asthma","volume":"70","author":"Wagener","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2023.07.026_bib0325","doi-asserted-by":"crossref","first-page":"22820","DOI":"10.1038\/s41598-021-02332-w","article-title":"Risk factors for the development of bronchiectasis in patients with asthma","volume":"11","author":"Ma","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.arbres.2023.07.026_bib0330","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1378\/chest.09-0174","article-title":"Qualitative analysis of high-resolution CT scans in severe asthma","volume":"136","author":"Gupta","year":"2009","journal-title":"Chest [Internet]"},{"key":"10.1016\/j.arbres.2023.07.026_bib0335","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/SMJ.0b013e31802fa16f","article-title":"The impact of bronchiectasis in clinical presentation of asthma","volume":"100","author":"Oguzulgen","year":"2007","journal-title":"South Med J [Internet]"},{"key":"10.1016\/j.arbres.2023.07.026_bib0340","doi-asserted-by":"crossref","first-page":"1700629","DOI":"10.1183\/13993003.00629-2017","article-title":"European Respiratory Society guidelines for the management of adult bronchiectasis","volume":"50","author":"Polverino","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2023.07.026_bib0345","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/02770903.2019.1579832","article-title":"Severe asthma and bronchiectasis","volume":"57","author":"Garc\u00eda-Clemente","year":"2020","journal-title":"J Asthma"},{"key":"10.1016\/j.arbres.2023.07.026_bib0350","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1183\/13993003.01862-2015","article-title":"Asthma and bronchiectasis exacerbation","volume":"47","author":"Mao","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2023.07.026_bib0355","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1164\/rccm.201208-1414OC","article-title":"Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study","volume":"187","author":"Hanania","year":"2013","journal-title":"Am J Respir Crit Care Med [Internet]"},{"key":"10.1016\/j.arbres.2023.07.026_bib0360","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/all.13072","article-title":"Allergy in severe asthma","volume":"72","author":"del Giacco","year":"2017","journal-title":"Allergy [Internet]"}],"container-title":["Archivos de Bronconeumolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289623002648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289623002648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:43:17Z","timestamp":1759531397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300289623002648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0300289623002648"],"URL":"https:\/\/doi.org\/10.1016\/j.arbres.2023.07.026","relation":{},"ISSN":["0300-2896"],"issn-type":[{"value":"0300-2896","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of Inflammatory Phenotype in Patients With Exacerbation-prone Asthma and Ongoing Therapy","name":"articletitle","label":"Article Title"},{"value":"Archivos de Bronconeumolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arbres.2023.07.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 SEPAR. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}